Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
91pct
130d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 558.
Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2025 · first_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies H.R. 9474 Patent Restoration Act (PERA) of 2024 S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies H.R. 9474 Patent Restoration Act (PERA) of 2024 S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
Issues related to patent policy. S.2220, the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act). S.2140, the Patent Eligibility Restoration Act. S.4713, the Inventor Diversity for Economic Advancement (IDEA) Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
Met with legislative staff to brief them on the potential negative impact on university technology transfer of intellectual property of NIST draft guidance on march-in rights. Encouraged potential legislative action to roll back this proposal if necessary. Encouraged legislative staff to support patent reform legislation (S 2220, S 2140, S 4713)
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Science/Technology
Science research funding HBCU/MSI research infrastructure funding The Deterrent Act S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) S. 2140, The Patent Eligibility Restoration Act (PERA) S. 4713, Inventor Diversity for Economic Advancement Act (IDEA)
Client expense: $115,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| IA |
| Richard Blumenthal | Democratic | CT |
| Richard J. Durbin | Democratic | IL |
| Thom Tillis | Republican | NC |
2024 · fourth_quarter · Copyright/Patent/Trademark
H.R. 4370 and S. 2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act A bill to amend title 35, United States Code, to invest in inventors in the United States, maintain the United States as the leading innovation economy in the world, and protect the property rights of the inventors that grow the economy of the United States, and for other purposes (ALL). H.R. 9474 and S. 2140: Patent Eligibility Restoration Act A bill to amend title 35, United States Code, to address matters relating to patent subject matter eligibility, and for other purposes (ALL). H.R. 9455 and S. 4713: Inventor Diversity for Economic Advancement (IDEA) Act A bill to amend chapter 11 of title 35, United States Code, to require the voluntary collection of demographic information for patent inventors, and for other purposes (ALL).
Client expense: $70,000 · Firm income: Not reported
2024 · fourth_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act Opposition to FTC proposal to limit non-compete agreements ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies H.R. 9474 Patent Restoration Act (PERA) of 2024
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Science/Technology
Invent Here, Make Here Act of 2024 (S.Amdt.2379); National Defense Authorization Act (NDAA) (S.4638); PREVAIL Act (S.2220); Patent Eligibility Restoration Act of 2023 (PERA) (S.2140); IDEA Act (S.4713); Economic Security and Diplomacy Act of 2024 (H.R. 10100) and other issues related to the Bayh-Dole Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
H.R. 5475 - Protecting American Patents Act H.R. 3535 - Advancing Americas Interests Act S. 2140 - Patent Eligibility Restoration Act S. 2220/H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) Act H.R. 5874 - Restoring Americas Leadership in Innovation Act NIST Draft Interagency Guidance Framework for Considering the exercise of March-In Rights (Docket No.: 230831-0207) H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024 S. 1956 - Invent Here, Make Here Act of 2023 S. 4713 - The IDEA Act (Inventor Diversity for Economic Advancement Act) S. 4840/ H.R. 9221 - Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2024
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
S. 2220 "PREVAIL Act", S. 2140 "Patent Eligibility Restoration Act", S. 4713 "IDEA Act"
Client expense: $130,000 · Firm income: Not reported
Government targets: SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
General discussions regarding patent-related issues, including march-in rights, WTO TRIPS waivers S. 2140/H.R. 9474 -- Patent Eligibility Restoration Act -- sections related to treatment of patent applications and their eligible status at the USPTO H.R 4370/S. 2220 -- PREVAIL Act -- related to reforms of the PTAB process at USPTO S. 4820/H.R. 9221 -- RESTORE Patent Rights Act -- related to reforms of patent law regarding injunctions against patent infringers H.R. 5475 -- Prohibiting Adversarial Patents Act -- To amend title 35, United State Code, to require the Director of the United States Patent and Trademark Office to require disclosures in patent applications regarding ties to the Peoples Republic of China and other foreign adversaries NIST Request for Information (Docket No. 230831-0207) Regarding the Draft Interagency Guidance Framework for Consideringthe Exercise of March-in Rights S. 4713 -- Inventor Diversity for Economic Advancement Act (IDEA) -- related to voluntary reporting of demographic information of patentees H.R. 8134 -- Restoring American Leadership in Innovation Act -- To promote the leadership of the United States in global innovation by establishing a robust patent system that restores and protects the right of inventors to own and enforce private property rights in inventions and discoveries, and for other purposes -- all sections
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
S. 2780, Medication Affordability and Patent Integrity Act S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 4875, Nurture Originals, Foster Art, and Keep Entertainment Safe Act of 2024 (NO FAKES Act) S.4713, Inventor Diversity for Economic Advancement Act of 2024 (IDEA Act) S. 3583, Bill to Address Patent Thickets Patent Act Section 101, S. S.2140, Patent Eligibility Restoration Act Preventing Abuse of Digital Replicas Act (PADRA) Patent Terminal Disclaimers
Client expense: $40,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2024 · third_quarter · Copyright/Patent/Trademark
Issues pertaining to march-in rights PREVAIL Act (S. 2220) Patent Eligibility Restoration Act (S.2140) Inventor Diversity for Economic Advancement (IDEA) Act (S. 4713)
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
Issues related to patent policy. S.2220, the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act). S.2140, the Patent Eligibility Restoration Act. S.4713, the Inventor Diversity for Economic Advancement (IDEA) Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act Opposition to FTC proposal to limit non-compete agreements ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act Opposition to FTC proposal to limit non-compete agreements ITC - IP-related issues S. 2934 - SHOP Safe Act of 2023 H.R. 8684 - Shop Safe Act Injunctive relief for patent rights holders The RESTORE Patent Rights ACT of 2024 (H.R. 9221) the IDEA Act (S.4713), the Medication Affordability and Patent Integrity Act (S.2780) Proposed Changes to Standard Essential Patent (SEPs) Policies
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220) [All] Patent Eligibility Restoration Act (S.2140) [All] Inventor Diversity for Economic Advancement Act (S. 4713) [All]
Client expense: $110,000 · Firm income: Not reported
Government targets: SENATE
2024 · third_quarter · Copyright/Patent/Trademark
Met with legislative staff to brief them on the potential negative impact on university technology transfer of intellectual property of NIST draft guidance on march-in rights. Encouraged potential legislative action to roll back this proposal if necessary. Encouraged legislative staff to support patent reform legislation (S 2220, S 2140, S 4713)
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
H.R. 4370 and S. 2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act A bill to amend title 35, United States Code, to invest in inventors in the United States, maintain the United States as the leading innovation economy in the world, and protect the property rights of the inventors that grow the economy of the United States, and for other purposes (ALL). H.R. 9474 and S. 2140: Patent Eligibility Restoration Act A bill to amend title 35, United States Code, to address matters relating to patent subject matter eligibility, and for other purposes (ALL). H.R. 9455 and S. 4713: Inventor Diversity for Economic Advancement (IDEA) Act A bill to amend chapter 11 of title 35, United States Code, to require the voluntary collection of demographic information for patent inventors, and for other purposes (ALL).
Client expense: $80,000 · Firm income: Not reported
2024 · third_quarter · Copyright/Patent/Trademark
S. 2220 "PREVAIL Act", S. 2140 "Patent Eligibility Restoration Act", S. 4713 "IDEA Act"
Client expense: $130,000 · Firm income: Not reported
Government targets: SENATE
2024 · third_quarter · Copyright/Patent/Trademark
S. 2780, Medication Affordability and Patent Integrity Act S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 4875, Nurture Originals, Foster Art, and Keep Entertainment Safe Act of 2024 (NO FAKES Act) S.4713, Inventor Diversity for Economic Advancement Act of 2024 (IDEA Act) Patent Act Section 101, S. S.2140, Patent Eligibility Restoration Act Preventing Abuse of Digital Replicas Act (PADRA) Patent Terminal Disclaimers
Client expense: $40,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2024 · third_quarter · Copyright/Patent/Trademark
H.R. 5475 - Protecting American Patents Act H.R. 3535 - Advancing Americas Interests Act S. 2140 - Patent Eligibility Restoration Act S. 2220/H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) Act H.R. 5874 - Restoring Americas Leadership in Innovation Act NIST Draft Interagency Guidance Framework for Considering the exercise of March-In Rights (Docket No.: 230831-0207) H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024 S. 1956 - Invent Here, Make Here Act of 2023 S. 4713 - The IDEA Act (Inventor Diversity for Economic Advancement Act) S. 4840/ H.R. 9221 - Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2024
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
S. 2220, the PREVAIL Act S. 2140, the Patent Eligibility Restoration Act of 2023 S. 4713, the Inventor Diversity for Economic Advancement (IDEA) Act of 2024 Bayh Dole Act intellectual property issues Commercialization and technology transfer issues Department of Commerce, National Institute of Standards and Technology (NIST) Notice; Request for Information (RFI) Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights; (Docket No.: 230831-0207)
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Science/Technology
Science research funding HBCU/MSI research infrastructure funding The Deterrent Act Tech Hubs Funding S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) S. 2140, The Patent Eligibility Restoration Act (PERA) S. 4713, Inventor Diversity for Economic Advancement Act (IDEA)
Client expense: $115,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
General discussions regarding patent-related issues, including march-in rights, WTO TRIPS waivers S. 2140/H.R. 9474 -- Patent Eligibility Restoration Act -- sections related to treatment of patent applications and their eligible status at the USPTO H.R 4370/S. 2220 -- PREVAIL Act -- related to reforms of the PTAB process at USPTO S. 4820/H.R. 9221 -- RESTORE Patent Rights Act -- related to reforms of patent law H.R. 5475 -- Prohibiting Adversarial Patents Act -- To amend title 35, United State Code, to require the Director of the United States Patent and Trademark Office to require disclosures in patent applications regarding ties to the Peoples Republic of China and other foreign adversaries NIST Request for Information (Docket No. 230831-0207) Regarding the Draft Interagency Guidance Framework for Consideringthe Exercise of March-in Rights S. 4713 -- Inventor Diversity for Economic Advancement Act (IDEA) -- related to voluntary reporting of demographic information of patentees Clauses in grants issued by ARPA-H regarding cost for inventions created using such funding H.R. 8134 -- Restoring American Leadership in Innovation Act -- To promote the leadership of the United States in global innovation by establishing a robust patent system that restores and protects the right of inventors to own and enforce private property rights in inventions and discoveries, and for other purposes -- all sections
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE